Rxi Pharmaceuticals Corp (NASDAQ:RXII)

3.48
Delayed Data
As of Feb 20
 +0.26 / +8.07%
Today’s Change
2.91
Today|||52-Week Range
11.20
-37.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash11.4M8.5M5.2M13.0M
 
 
 
 
 
Short Term Investment Cash6.3M-2.9M-3.4M7.8M
 
 
 
 
 
Cash & Short Term Investments14.4M8.5M10.7M13.0M
 
 
 
 
 
 
ReceivablesReceivables----0.000.00--
 
InventoriesInventories----0.000.00--
 
Current AssetsPrepaid Expenses----311.0K150.0K
 
 
 
Other Current Assets303.0K442.0K0.000.00
 
 
 
Current Assets14.7M9.0M11.0M13.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross809.0K885.0K941.0K945.0K
 
 
 
 
 
Depreciation-632.0K-702.0K-778.0K-831.0K
 
 
 
 
 
Other Assets18.0K18.0K18.0K22.5K
 
 
 
 
 
Total Assets14.9M9.2M11.2M13.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable163.0K285.0K1.2M917.0K
 
 
 
 
 
Accrued Expenses985.0K469.0K1.1M880.0K
 
 
 
 
 
Other Current Liabilities1.3M521.0K1.1M880.0K
 
 
 
 
 
Other Liabilities2.1M1.3M2.3M2.5M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities2.1M1.3M2.3M2.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock10.0M6.7M0.003.5M
 
 
 
 
Common Equity2.9M1.2M8.9M7.3M
 
 
 
 
 
Total Shareholder Equity12.9M7.9M8.9M10.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding117.9K219.8K653.5K1.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.